Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000070

General Counsel returned 8,067 shares (to the company)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tang Carolyn C. · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-18 Returned to the company : show line 1 in the form 10b5-1 −3,991 $17.74 $70,800 91,955 D
2023-12-19 Returned to the company : show line 2 in the form 10b5-1 −4,076 $18.09 $73,735 87,879 D
Loading xslF345X05/wk-form4_1703106643.xml…